Metastatic HER2-Low Breast Carcinoma trials recruiting in Massachusetts

Fewer than 3 recruiting trials found.

All Metastatic HER2-Low Breast Carcinoma trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
  NCT07137416 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston